Ranibizumab Fails to Beat Saline in Avoiding VitrectomyRanibizumab Fails to Beat Saline in Avoiding Vitrectomy

Patients with vitreous hemorrhage from proliferative diabetic retinopathy who received intravitreal injections of ranibizumab or saline had about the same rates of vitrectomy by 16 weeks. Medscape Medical News

Source: Medscape Today Headlines - February 1, 2013 Category: Consumer Health News Tags: Ophthalmology News Source Type: news